| scholarly article | Q13442814 |
| P2093 | author name string | Chan LY | |
| Wallace SM | |||
| P2860 | cites work | Animal model distinguishing in vitro from in vivo carbenicillin-aminoglycoside interactions | Q33735045 |
| Interactions of Carbenicillin and Ticarcillin with Gentamicin | Q34925289 | ||
| Stability of gentamicin in serum | Q34983093 | ||
| Interactions between aminoglycoside antibiotics and carbenicillin or ticarcillin | Q39103545 | ||
| Gentamicin in 1978 | Q39773510 | ||
| Gentamicin inactivation by piperacillin or carbenicillin in patients with end-stage renal disease | Q39856493 | ||
| Effect of Time and Concentration Upon Interaction Between Gentamicin, Tobramycin, Netilmicin, or Amikacin and Carbenicillin or Ticarcillin | Q40620360 | ||
| Inactivation of gentamicin by penicillins in patients with renal failure | Q40946710 | ||
| In Vitro Evaluation of Tobramycin, a New Aminoglycoside Antibiotic | Q41027689 | ||
| Gentamicin and Ticarcillin Serum Levels | Q41575281 | ||
| Stability of gentamicin, tobramycin, and amikacin in combination with four beta-lactam antibiotics | Q41963259 | ||
| Effect of piperacillin on tobramycin pharmacokinetics in patients with normal renal function | Q42086414 | ||
| Tobramycin inactivation by carbenicillin, ticarcillin, and piperacillin | Q42115574 | ||
| Inactivation of amikacin and gentamicin by carbenicillin in patients with end-stage renal failure | Q42926887 | ||
| Carbenicillin inactivation of aminoglycosides in patients with severe renal failure | Q44806057 | ||
| Inactivation of netilmicin by carbenicillin | Q44959812 | ||
| Gentamicin plus carbenicillin | Q44971607 | ||
| Clinical and laboratory evidence for inactivation of gentamicin by carbenicillin. | Q54170509 | ||
| Carbenicillin plus gentamicin. | Q54259175 | ||
| Biological aspects of the interaction between gentamicin and carbenicillin | Q54659942 | ||
| Effect of concentration and time upon inactivation of tobramycin, gentamicin, netilmicin and amikacin by azlocillin, carbenicillin, mecillinam, mezlocillin and piperacillin. | Q55062572 | ||
| Aminoglycoside inactivation by penicillins and cephalosporins and its impact on drug-level monitoring. | Q55062708 | ||
| Ticarcillin vs carbenicillin: Clinical pharmacokinetics | Q66918775 | ||
| Stability of gentamicin and cefamandole in serum | Q70327774 | ||
| Temperature dependence of the stability of tobramycin mixed with penicillins in human serum | Q70420027 | ||
| Laboratory and Clinical Conditions for Gentamicin Inactivation by Carbenicillin | Q70505279 | ||
| High-pressure liquid chromatographic assays for ticarcillin in serum and urine | Q70517942 | ||
| In vitro inactivation of gentamicin, tobramycin, and netilmicin by carbenicillin, azlocillin, or mezlocillin | Q70553432 | ||
| Comparative aminoglycoside inactivation by beta-lactam antibiotics. Effects of a cephalosporin and six penicillins on five aminoglycosides | Q70602900 | ||
| Interactions of moxalactam and tobramycin in normal volunteers and in patients with impaired renal function | Q71261707 | ||
| Stability of tobramycin sulfate mixed with oxacillin sodium and nafcillin sodium in human serum | Q71267557 | ||
| Gentamicin plus carbenicillin | Q93696913 | ||
| Therapeutic implications of interaction of gentamicin and penicillins | Q93709070 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 274-281 | |
| P577 | publication date | 1985-08-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | In vitro interaction of aminoglycosides with beta-lactam penicillins | |
| P478 | volume | 28 |
| Q42465266 | AZDAST the new horizon in antimicrobial synergism detection |
| Q54296189 | Accumulation of amikacin in synovial fluid after regional limb perfusion of amikacin sulfate alone and in combination with ticarcillin/clavulanate in horses. |
| Q68855421 | Activity of cefotiam in combination with beta-lactam antibiotics on enterobacterial hospital strains |
| Q36632795 | Antibiotic combinations: should they be tested? |
| Q46145943 | Circadian variation in serum amikacin levels |
| Q35246505 | Effect of concomitant administration of piperacillin on the dispositions of netilmicin and tobramycin in patients with end-stage renal disease |
| Q57435586 | In Vitro Elution of Amikacin and Ticarcillin from a Resorbable, Self-Setting, Fiber Reinforced Calcium Phosphate Cement |
| Q40085677 | In vitro inactivation of aminoglycosides by sulbactam, other beta-lactams, and sulbactam-beta-lactam combinations |
| Q46502081 | Lack of in vitro inactivation of tobramycin by imipenem/cilastatin. |
| Q48169819 | Multi-drug-resistant Enterococcus spp. as a cause of non-responsive septic synovitis in three horses |
| Q37046067 | Pharmacokinetics of a combination of amikacin sulfate and penicillin G sodium for intravenous regional limb perfusion in adult horses |
| Q92372885 | Pharmacokinetics of regional limb perfusion using a combination of amikacin and penicillin in standing horses |
| Q35258719 | Role of sodium in protection by extended-spectrum penicillins against tobramycin-induced nephrotoxicity |
Search more.